FIRINU, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 222.091
NA - Nord America 11.322
AS - Asia 6.547
SA - Sud America 1.195
AF - Africa 224
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
Totale 241.410
Nazione #
IT - Italia 218.555
US - Stati Uniti d'America 11.046
SG - Singapore 2.480
CN - Cina 1.968
BR - Brasile 914
SE - Svezia 728
VN - Vietnam 646
DE - Germania 621
FI - Finlandia 486
UA - Ucraina 442
FR - Francia 341
GB - Regno Unito 328
HK - Hong Kong 314
IN - India 187
NL - Olanda 150
CA - Canada 148
BD - Bangladesh 134
KR - Corea 134
TR - Turchia 107
AR - Argentina 91
MX - Messico 72
JP - Giappone 70
AT - Austria 69
ZA - Sudafrica 66
RU - Federazione Russa 58
ID - Indonesia 56
IQ - Iraq 54
PK - Pakistan 51
ES - Italia 48
MA - Marocco 45
CO - Colombia 44
IE - Irlanda 44
PL - Polonia 43
EC - Ecuador 41
PH - Filippine 40
SA - Arabia Saudita 34
UZ - Uzbekistan 33
VE - Venezuela 33
IR - Iran 30
CL - Cile 26
BE - Belgio 25
MY - Malesia 25
JO - Giordania 23
IL - Israele 22
KE - Kenya 22
EG - Egitto 21
AU - Australia 20
AE - Emirati Arabi Uniti 16
TH - Thailandia 16
TN - Tunisia 16
LT - Lituania 15
RO - Romania 15
PT - Portogallo 13
AZ - Azerbaigian 12
CH - Svizzera 12
CR - Costa Rica 12
JM - Giamaica 12
PY - Paraguay 12
DZ - Algeria 11
OM - Oman 11
TW - Taiwan 11
BO - Bolivia 10
CZ - Repubblica Ceca 10
NP - Nepal 10
UY - Uruguay 10
NG - Nigeria 9
PE - Perù 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
GE - Georgia 7
LB - Libano 7
PS - Palestinian Territory 7
BG - Bulgaria 6
GR - Grecia 6
HU - Ungheria 6
MU - Mauritius 6
NO - Norvegia 6
AL - Albania 5
AO - Angola 5
CI - Costa d'Avorio 5
EE - Estonia 5
HN - Honduras 5
IS - Islanda 5
KG - Kirghizistan 5
KW - Kuwait 5
LV - Lettonia 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
PA - Panama 5
RS - Serbia 5
BN - Brunei Darussalam 4
BY - Bielorussia 4
ET - Etiopia 4
EU - Europa 4
HR - Croazia 4
LU - Lussemburgo 4
MD - Moldavia 4
SN - Senegal 4
SY - Repubblica araba siriana 4
Totale 241.353
Città #
Cagliari 212.074
Uta 5.126
Singapore 1.354
Ashburn 1.195
San Jose 889
Fairfield 800
Dallas 777
Woodbridge 559
Boardman 549
Chandler 534
Houston 472
Nyköping 405
Beijing 401
Helsinki 375
Wilmington 329
Council Bluffs 301
Seattle 289
Los Angeles 286
Hong Kong 272
Cambridge 252
Ann Arbor 246
Munich 238
Jacksonville 208
Santa Clara 198
New York 197
Hefei 186
Ho Chi Minh City 182
Lauterbourg 171
Shanghai 168
Hanoi 133
The Dalles 126
Seoul 115
Rome 114
Boston 111
Dearborn 110
Milan 103
Dong Ket 102
São Paulo 91
Nanjing 83
Buffalo 82
Frankfurt am Main 77
San Diego 74
Redwood City 65
Guangzhou 64
Redondo Beach 64
Orem 59
Toronto 55
London 53
Chicago 52
Amsterdam 51
Chennai 48
Brooklyn 46
Tokyo 46
Nuremberg 44
Vienna 44
Washington 43
Atlanta 40
Montreal 36
Paris 35
Rio de Janeiro 33
Changsha 32
Johannesburg 32
Dublin 31
Nanchang 31
Tashkent 31
Tianjin 31
Verona 31
Denver 27
Phoenix 27
Shenyang 27
Warsaw 27
Jiaxing 26
Lappeenranta 26
Casablanca 25
Mexico City 25
Stockholm 25
Turin 24
Ankara 23
Belo Horizonte 23
Columbus 23
Florence 23
Haiphong 23
Sassari 23
Birmingham 22
Manchester 22
San Francisco 22
Zhengzhou 22
Düsseldorf 21
Kocaeli 21
Monserrato 21
Da Nang 20
Turku 20
Brussels 19
Curitiba 19
Mountain View 19
Amman 18
Jakarta 18
Mumbai 18
Norwalk 18
Baghdad 17
Totale 232.185
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.836
Overexpression of the cytokine BAFF and autoimmunity risk 4.130
TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome 4.015
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 3.880
The salivary proteome profile in patients affected by SAPHO syndrome characterized by a top-down RP-HPLC-ESI-MS platform 3.872
Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease. 3.544
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.300
Zinc status and autoimmunity: A systematic review and meta-analysis 3.114
The Salivary Proteome Profile in Patients Affected by SAPHO Syndrome characterized by a top-down RP-HPLC-ESI-MS platform 3.017
Vaping effects on asthma: results from a web survey and clinical investigation 2.981
Proteomic Analysis of the Acid-Insoluble Fraction of Whole Saliva from Patients Affected by Different Forms of Non-histaminergic Angioedema 2.798
Characterization of patients with angioedema without wheals: The importance of F12 gene screening 2.788
COVID-19 in the mediterranean area: Epidemiology and main disease characteristics - A narrative review 2.787
Fungal allergy in asthma 2.760
SAPHO Syndrome: Current developments and approaches to clinical treatment 2.747
Alteration of the salivary secretory proteome profile in adults affected by antibody deficiency diseases 2.736
Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report 2.723
Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis 2.707
RP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody Deficiencies 2.626
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 2.553
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 2.480
Biological treatments for SAPHO syndrome: an update 2.462
Evaluation of olfactory function as a potential biomarker in patients with Mastocytosis 2.436
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.432
Baricitinib exposure during pregnancy in rheumatoid arthritis 2.332
Oxidative stress markers in patients with hereditary angioedema 2.301
Alteration of the Salivary Secretory Proteome Profile in Adults Affected by Immune Deficiency Diseases 2.289
Biologics for ANCA-associated vasculitis 2.237
Increased peripheral T(H)17 Cells in SAPHO syndrome: a novel target for treatment? 2.228
Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie = Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic 2.199
Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study 2.177
Genetic variants regulating immune cell levels in health and disease 2.134
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 2.025
Periodic fever syndromes and autoinflammatory diseases: a case series from an Italian centre 2.015
An uncommon cause of refractory pleural effusion in an elderly patient 2.015
Clinical pitfalls of leishmaniasis and Whipple’s disease hidden behind systemic lupus erythematosus: A case series 2.003
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 1.939
The role of genetics in the current diagnostic workup of idiopathic non-histaminergic angioedema 1.937
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.917
Mutation of angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema 1.816
Relevance of essential trace elements in nutrition and drinking water for human health and autoimmune disease risk 1.802
Asthma and psychiatric disorders 1.798
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma 1.770
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 1.746
Genetic factors associated with levels of immune cell types 1.717
The climate in the European Union and the enlarged European Region is a determinant of the COVID-19 case fatality ratio 1.703
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.698
Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force 1.671
EAACI Biologicals Guidelines—Recommendations for severe asthma 1.651
Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery 1.637
Exercise and asthma: an overview 1.591
Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole 1.590
Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: a case report 1.587
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma 1.557
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype 1.543
The COVID-19 incidence in Italian regions correlates with low temperature, mobility and PM10 pollution but lethality only with low temperature 1.539
Is hereditary angioedema related to an increased risk of atherosclerosis? 1.530
Management of Intermittent and Persistent Asthma in Adolescent and High School Athletes 1.473
Hyperosinophilia and recurrent angioedema in a patient with giant cell arteritis: a diagnostic "glitch" in a case of Gleich's syndrome 1.469
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.452
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout 1.440
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 1.424
Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy 1.395
Celiac disease: peripheral blood cell-mediated response to antigen-specific stimulation 1.388
Eosinophilic granulomatosis with polyangiitis relapse after covid-19 vaccination: A case report 1.382
Biologics for SAPHO syndrome: a single centre experience 1.373
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.355
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.332
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 1.325
COVID-19 Case Fatality Ratio of Latino America Countries with Temperate Climate Partially Follows European and Oceania Trends According to Seasonal Change 1.268
Metabolomics, microbiota, and in vivo and in vitro biomarkers in type 2 severe asthma: A perspective review 1.263
Melkersson-Rosenthal Syndrome: A case report 1.260
Urticaria and angioedema as possible misleading skin symptoms in families with hereditary angioedema 1.241
An uncommon association of antiphospholipid syndrome, selective IgA deficiency and resistant-to-treatment relapsing polychondritis: efficacy of Infliximab 1.238
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.236
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.226
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 1.221
Olfactory Function Is Impaired in Patients with Mastocytosis 1.199
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma 1.191
Idiopathic pyoderma gangrenosum: Successful resolution with Infliximab therapy and proinflammatory cytokines assessment 1.183
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 1.168
Angioedema without wheals: a retrospective analysis of a single center cohort 1.141
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 1.141
Raynaud's phenomenon and scleroderma associated with silicone gel breast implants: An example of Asia syndrome 1.129
Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: An interesting finding that deserves further studies 1.110
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G 1.100
Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency 1.087
Previous functional social and behavioral rhythms affect resilience to COVID-19-related stress among old adults 1.071
Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab 1.060
Adult antibody deficiency syndrome and Henoch-Schoenlein Purpura: a report of two cases 1.052
Salivary Cystatin D Interactome in Patients with Systemic Mastocytosis: An Exploratory Study 1.045
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: A case report 1.012
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 1.003
A promising new treatment for SAPHO syndrome that deserves further studies 996
Cofactors, age at onset, allergic comorbidities and gender are different in patients sensitized to omega-5 gliadin and Pru p 3 937
A Novel Mutation in the SERPING1 Gene in Patients with Hereditary Angioedema and a Coexistent Complement Deficiency 935
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 932
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic. Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H 931
COVID-19 Vaccine Hesitancy among Italian Healthcare Workers: Latent Profiles and Their Relationships to Predictors and Outcome 909
Covid-19 vaccines work but other factors play a relevant role: a data analysis on spread and mortality in 24 countries 881
Totale 202.392
Categoria #
all - tutte 319.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 319.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.740 0 0 0 0 0 0 0 0 0 0 0 1.740
2021/202212.565 1.277 721 586 986 922 896 795 607 1.311 1.144 1.659 1.661
2022/202317.536 1.347 2.302 2.432 1.366 1.532 1.814 944 1.546 1.052 991 1.336 874
2023/202420.785 1.275 781 979 1.614 1.945 3.424 3.046 1.666 992 1.354 1.797 1.912
2024/202575.152 15.887 35.053 7.619 4.366 3.292 2.562 3.563 358 665 526 496 765
2025/202614.683 950 811 1.469 1.052 1.169 954 3.413 808 1.127 1.588 810 532
Totale 242.134